Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Exoribonuclease 1 (ERI1) (C-Term) Peptide

ERI1 Hôte: Synthetic BP, WB
N° du produit ABIN8100069
168,15 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 6 à 9 jours ouvrables

Aperçu rapide pour Exoribonuclease 1 (ERI1) (C-Term) Peptide (ABIN8100069)

Antigène

ERI1 (Exoribonuclease 1 (ERI1))

Source

  • 4
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    C-Term

    Fonction

    THEX1 Peptide - C-terminal region
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Commentaires

    This is a synthetic peptide designed for use in combination with anti-THEX1 antibody ( ARP41158_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Buffer

    Lyophilized powder

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
  • Antigène

    ERI1 (Exoribonuclease 1 (ERI1))

    Sujet

    Background Information: THEX1 contains 1 SAP domain and 1 exonuclease domain. It is an RNA exonuclease that binds to the 3' end of histone mRNAs and probably degrades them, suggesting that it plays an essential role in histone mRNA decay after replication. It is also able to degrade the 3' overhangs of short interfering RNAs (siRNAs) in vitro, suggesting a possible role as regulator of RNA interference (RNAi).

    Alternative Symbols: HEXO, THEX1, 3'HEXO

    Poids moléculaire

    38kDa

    ID gène

    90459

    NCBI Accession

    NP_699163

    UniProt

    Q8IV48
Vous êtes ici:
Chat with us!